UNSPSC 51282705: Vancomycin monohydrochloride

This classification denotes an antibiotic with the molecular formula C66H75Cl2N9O24.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 71WO621TJD, chemically known as vancomycin, monohydrochloride, but more generally known as vancomycin monohydrochloride, which bears US NIH Compound Identifier 14970. European Medicines Agency schedules vancomycin monohydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05076MIG.

Most nations, for tariff purposes, schedule vancomycin monohydrochloride under HS 29419000. SMILES:.

UNSPSC 51282705 Vancomycin mononohydrochloride is a Commodity code that encompasses pharmaceutical products procured by state and local health agencies, but the recent opportunities tagged under this code show minimal direct alignment with vancomycin specifically. Instead, state and local buyers are using this code to solicit broader pharmaceutical procurement — generic multi-source drugs, over-the-counter products, naloxone and drug deactivation systems, and first-aid supplies. The issuing bodies include state health and human services departments (Texas HHS Commission), cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon), county health departments (Seminole County, Florida), and municipal fire and rescue divisions (City of Tampa). The scope reflects high-volume commodity purchasing with strict compliance requirements including Good Manufacturing Practices certification, Drug Supply Chain Security Act compliance, FDA standards, and expiration-date thresholds (typically six months to nine months minimum shelf life). Vendors must maintain substantial insurance coverage, work with authorized wholesalers in three-tier distribution networks, and accept performance penalties for non-compliance.

Recent activity spans Florida, Texas, Minnesota, and Oregon. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 on January 20, 2026, seeking generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026, using authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) and a two-year initial contract term. The City of Tampa issued IFB 26P00145 on March 25, 2026, for medical and first-aid supplies (169 line items, $700,000 estimated value) due March 13, 2026, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. Seminole County, Florida solicited naloxone and drug deactivation systems (IFB60459723LAS, posted June 30, 2026) for quarterly delivery with a two-year initial term and one-year renewal option. The Texas HHS Commission issued RFI HHS0017013 in April 2026 to gather market intelligence on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels, signaling potential future formalized procurement.